Howard G. Smith probes GE HealthCare after 13.2% stock drop

The law firm said it is investigating possible federal securities law violations after GE HealthCare cut 2026 adjusted EPS guidance and disclosed a PDx supplier-related recall impact.

Summary

The Law Offices of Howard G. Smith said it is investigating GE HealthCare Technologies Inc. over possible federal securities law violations tied to the company's April 29, 2026 first-quarter results and subsequent disclosures. GE HealthCare reported adjusted earnings per share of $0.99 and lowered its full-year 2026 adjusted EPS guidance to $4.80 to $5.00 from $4.95 to $5.15. During the related earnings call, management said first-quarter profit performance was affected by "a recall associated with a PDx supplier" and that year-over-year margin performance was also hurt by declines in PCS and the PDx supplier issue. GE HealthCare shares fell $9.01, or 13.2%, to close at $59.49 on April 29, 2026. The release also noted that on July 23, 2026, the company said Chief Financial Officer Jay Saccaro would step down and that an interim CFO would be appointed while a permanent replacement is sought.

Terms & Concepts
  • adjusted EPS guidance: Company forecast for adjusted earnings per share